Literature DB >> 16342680

[Inhibition of the expression of prostate specific antigen by curcumin].

Lei Yang1, Lian-Ying Zhang, Wei-Wen Chen, Feng Kong, Peng-Ju Zhang, Xiao-Yan Hu, Jian-Ye Zhang, Fu-Ai Cui.   

Abstract

AIM: To study the effect of curcumin on the expression of prostate specific antigen (PSA).
METHODS: AXSYM system-chemical luciferase method was used to examine the content of PSA in prostate cancer cell lines, LNCap after treated with different doses of curcumin. pGL3-PSA luciferase expression vector, containing 640 bp DNA of PSA gene 5' promoter region was constructed and transfected into LNCap cell with lipofectin. Through detecting the activity of luciferase, the effect of curcumin on the promoter of PSA was studied. Western blotting was used to detect expression of androgen receptor (AR) in LNCap cell with different concentrations of curcumin.
RESULTS: The expression of PSA was inhibited and activity of luciferase was reduced by curcumin. There was also significant difference in AR expression as shown by Western blotting experiment after treatment of different doses of curcumin.
CONCLUSION: Through inhibiting AR expression, curcumin reduced the function of PSA promoter and inhibited PSA protein expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16342680

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  4 in total

1.  Inhibitory effect of matrine on the expression of PSA and AR in prostate cancer cell line LNCaP.

Authors:  Ke Chen; Zhiquan Hu; Tao Wang; Hui Guo; Zhangqun Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

Review 2.  Changing perspectives regarding late-life dementia.

Authors:  Majid Fotuhi; Vladimir Hachinski; Peter J Whitehouse
Journal:  Nat Rev Neurol       Date:  2009-11-17       Impact factor: 42.937

Review 3.  Chinese Medicines in the Treatment of Prostate Cancer: From Formulas to Extracts and Compounds.

Authors:  Xueni Wang; Gang Fang; Yuzhou Pang
Journal:  Nutrients       Date:  2018-02-28       Impact factor: 5.717

4.  Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy.

Authors:  Bakheet E M Elsadek; Mohammed H Hassan
Journal:  Biochem Biophys Rep       Date:  2021-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.